As of Nov 27
| -0.09 / -4.62%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +88.17% increase from the last price of 1.86.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.